Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nemonoxacin in Community-Acquired Pneumonia
NCT01537250Phase 2Completed
- Sponsor
- TaiGen Biotechnology Co., Ltd.
- Start
- Aug 2009
- Primary completion
- Aug 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of nemonoxacin in community acquired pneumonia (CAP), sponsored by TaiGen Biotechnology Co., Ltd.. Started Aug 2009; status: completed.
02
Drugs
nemonoxacin
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT01537250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01537250.